There are new available articles, click to refresh the page.

FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time

— June 4^th 2024 at 09:26

The U.S. Food and Drug Administration held a meeting to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder for the first time.